Key result
Compound heterozygous FKTN variants cause cardiac-predominant Fukutinopathy with clinically silent skeletal myopathy.
Why the study?
Cardiac-predominant presentations of Fukutinopathy without overt neuromuscular manifestations are uncommon and underrecognized.
Case Report (n=1)
No
This case report expands the clinical spectrum of Fukutinopathy to include cardiac-predominant phenotypes, highlighting the importance of comprehensive genetic testing in selected patients with unexplained nonischemic cardiomyopathy.
Alerts clinicians to fukutinopathy in unexplained cardiomyopathy with hyperCKemia; extends cardiac phenotype but leaves practice implications open pending larger studies.
BACKGROUND: Fukutinopathy is a rare autosomal recessive dystroglycanopathy caused by pathogenic FKTN variants. Cardiac-predominant presentations without overt neuromuscular manifestations are uncommon. CASE SUMMARY: We report a 30-year-old Indian man with dilated cardiomyopathy, persistent QT prolongation, subepicardial late gadolinium enhancement on cardiac magnetic resonance imaging, and hyperCKemia. Whole-exome sequencing identified compound heterozygous FKTN variants: c.1112A > G (p.Tyr371Cys; likely pathogenic) and c.1224G > T (p.Lys408Asn; variant of uncertain significance). Parental Sanger sequencing confirmed trans inheritance. Genotype-directed evaluation subsequently revealed clinically silent skeletal myopathy. Guideline-directed medical therapy was initiated, and left ventricular systolic function remained stable at 6-month follow-up. CONCLUSIONS: This case expands the cardiac spectrum of Fukutinopathy by demonstrating a cardiac-predominant phenotype with subclinical myopathy. Comprehensive genetic evaluation with segregation analysis should be considered in selected patients with unexplained nonischemic cardiomyopathy, even in the absence of overt neuromuscular features.
No takes yet. Share an insight, caveat, or question.
Imayavaramban et al. (2026) conducted a case report in Fukutinopathy with dilated cardiomyopathy (n=1). Compound heterozygous FKTN variants (c.1112A > G and c.1224G > T) was evaluated. Compound heterozygous FKTN variants (c.1112A > G and c.1224G > T) can cause a cardiac-predominant Fukutinopathy phenotype with clinically silent skeletal myopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: